Improving Participation After Stroke Self-Management-Rehabilitation
Launched by UNIVERSITY OF MISSOURI-COLUMBIA · Sep 6, 2024
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new program designed to help people who have had a mild or moderate stroke manage their recovery better. The focus is on teaching participants skills to boost their confidence, improve their daily activities, and enhance their overall quality of life, all through small group sessions conducted online. This means that participants can join from home, making it easier to stay engaged in their recovery process.
To be part of this study, participants should be between 45 and 85 years old, have had a stroke less than six months ago, and have finished any recommended rehabilitation in a hospital. They also need to be able to understand and communicate in English and use video conferencing tools, either on their own or with help. The trial is currently recruiting participants, and it aims to provide valuable support for those recovering from stroke while ensuring that everyone involved can safely participate in the program.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • less than 6 months post-stroke
- • age 45-85 years
- • completed inpatient rehabilitation services (if recommended)
- • living in the community with or without caregiver support (i.e., not living in a skilled nursing facility)
- • ability to read, write, and speak English
- • diagnosis of mild or moderate stroke (National Institutes of Health stroke score \<16)
- • able to use videoconferencing independently or with caregiver support
- Exclusion Criteria:
- • severe depressive symptoms as indicated by a score ≥21 on the Patient Health Questionnaire
- • dementia symptoms as indicated by a score of \<23 on the Montreal Cognitive Assessment
- • additional neurological diagnoses (e.g., brain malignancy, previous severe stroke)
- • (4) moderate or severe aphasia as indicated by a National Institutes of Health Stroke Scale aphasia score of ≥ 2
- • inability to provide informed consent
- • any other condition not otherwise specified that the PI determines would render participation in this study as unsafe for the participant
About University Of Missouri Columbia
The University of Missouri-Columbia is a leading academic institution dedicated to advancing medical research and clinical innovation. As a prominent sponsor of clinical trials, the university leverages its extensive resources and expertise to facilitate groundbreaking studies aimed at improving patient outcomes across a variety of health conditions. With a commitment to ethical research practices and collaboration with multidisciplinary teams, the University of Missouri-Columbia strives to translate scientific discoveries into effective therapeutic interventions, ultimately enhancing the quality of care in the communities it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbia, Missouri, United States
Patients applied
Trial Officials
Anna E Boone, PhD, OTR/L
Principal Investigator
University of Missouri Occupational Therapy
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported